25 of the Best Transplant Surgeons Near Me in charleston, SC

Dr. Brian Houston is a cardiologist specializing in the management of advanced heart failure, including the care of patients before and after heart transplantation or left ventricular assist device (LVAD). After graduating from Emory University School of Medicine, Dr. Houston completed residency at Johns Hopkins Hospital in Baltimore, Maryland. He was invited to serve as an assistant chief of service of the Thayer Firm at Johns Hopkins Hospital, and he spent that year caring for patients and instructing residents and medical students. He remained at Johns Hopkins for his general cardiology fellowship and spent an additional year of fellowship there training in the care of advanced heart failure, LVADs, and transplantation. Dr. Houston has been invited to present his research work at international scientific meetings. He has a particular interest in cardiac sarcoidosis and in the effects of LVAD support on the gastrointestinal tract, blood, and the right side of the heart. He was honored to be named a finalist for the American Heart Association's Young Clinician Award in 2015. Dr. Houston believes that each patient with heart failure is unique and that, to live their best life, they require a caring and comprehensive approach from a dedicated medical team. Dr. Houston is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiomyopathy, Heart Transplant, and Lung Transplant. Dr. Houston is currently accepting new patients.

Dr. Sheldon E. Litwin is a cardiologist with nationally recognized expertise in advanced cardiac imaging and its use in the diagnosis of heart disease and treatment of patients with heart disease. Dr. Litwin is board-certified in general cardiology, nuclear cardiology, echocardiography, and cardiovascular computed tomography (CT). He was recognized in 2014 in America's Top Doctors (Castle Connolly Medical Ltd.). He is a strong proponent of preventive cardiology and has a longstanding interest in weight loss as prevention and treatment for cardiovascular disease. He is an avid outdoorsman and exercise advocate who is passionate about caring for active adults who participate in sports or recreational exercise. Prior to coming to MUSC Health, Dr. Litwin was chief of the division of cardiology at Georgia Regents University from 2011 to 2014 and director of cardiac imaging at the University of Utah from 1993 to 2011. Dr. Litwin is involved in clinical trials using new therapies for heart failure with preserved ejection fraction (HFpEF). He has published more than 100 scientific papers and serves on several editorial boards and national committees.Dr. Litwin's medical degree was awarded by Washington University School of Medicine. He completed a residency at the University of Arizona and completed a cardiology fellowship at Beth Israel Hospital, Harvard Medical School. Dr. Litwin is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Gastric Bypass, and Aortic Valve Replacement. Dr. Litwin is currently accepting new patients.

Prabhakar Baliga, M.D. FACS is a transplant surgeon and chair of the MUSC Department of Surgery, where he leads a diverse range of programs and services spanning nine clinical divisions, in addition to the Department's research and education divisions. Dr. Baliga's philosophy is to treat his patients with a primary focus on excellence and compassionate care. His clinical focus is in abdominal organ transplant with a special interest in kidney, liver and pancreas transplantation. He treats patients who are experiencing kidney failure, particularly with polycystic kidney disease; liver failure, liver cancer and patients who have issues with their bile duct, a series of thin tubes that go from the liver to the small intestine. ,He has served many leadership positions that have positively impacted the growth and expertise of the MUSC Health transplant program, the only solid organ transplant center in South Carolina. Prior to assuming the role of Department Chair, Dr. Baliga was named MUSC's ICCE Leader for Transplant, Nephrology & Hepatology and served on the Board of Life Point, an organ procurement agency. He has also served on the board for the United Network for Organ Sharing and the board of directors for the South Carolina chapter of the National Kidney Foundation. He is on the leadership of the state-wide SC surgical quality collaborative that is focused on improving care of surgical patients across SC. He currently serves on the American College of Surgeons Board of Governors as the Surgical Specialty Society Governor from the Southern Surgical Association.Dr. Baliga was awarded his medical degree by Madras Medical College in India. He completed his surgical residency at Tulane University and his transplant fellowship at the University of Michigan. Dr. Baliga is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Kidney Transplant, and Pancreas Transplant. Dr. Baliga is currently accepting new patients.

John Mcgillicuddy is a Transplant Surgeon practicing medicine in Charleston, South Carolina. Dr. Mcgillicuddy is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Alcoholic Cirrhosis, Liver Failure, Hepatitis, Kidney Transplant, and Liver Transplant. Dr. Mcgillicuddy is currently accepting new patients.

Dr. Daniel Judge is a professor of medicine in cardiology at MUSC. He received his medical degree at the University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology, and advanced heart failure/transplant cardiology at Johns Hopkins. He is board-certified in both cardiology and advanced heart failure/transplant cardiology.Dr. Judge takes care of adult patients with inherited forms of cardiovascular disease, as well as congestive heart failure. As director of the cardiovascular genetics program, Dr. Judge has extensive experience caring for individuals and families with inherited forms of cardiomyopathy, aortic aneurysm, amyloidosis, and cardiac involvement from other genetic conditions.He has authored more than 150 scientific manuscripts. Dr. Judge is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation. Dr. Judge is currently accepting new patients.

Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Scleroderma, Heart Transplant, and Lung Transplant. Dr. Tedford is currently accepting new patients.

Dr. Zile is a graduate of Rush University School of Medicine. He did his internal medicine residency at Rush Presbyterian St. Lukes Medical Center in Chicago, a clinical cardiology fellowship at Tufts-New England Medical Center in Boston and a research cardiology fellowship at the Department of Veterans Affairs Medical Center, Boston. Dr. Zile is currently the Charles Ezra Daniel professor of medicine at the Medical University of South Carolina.He also serves as the director of cardiology at the Ralph H. Johnson Department of Veteran's Affairs Medical Center in Charleston. He is an adjunct professor of bioengineering at Clemson University.Dr. Zile's research career has involved both basic laboratory research examining the mechanisms of disease development and progression and translational clinical research examining the application of these basic mechanisms to development of effective treatment methods.Dr. Zile is a recognized leader in the areas of cardiac function, congestive heart failure, diastolic heart failure and valvular heart disease. His research is supported by grants from the National Heart, Lung and Blood Institute, the American Heart Association, the Department of Veterans Affairs and the Medical University of South Carolina.Dr. Zile is the author of over 100 peer-reviewed publications. He is a member of a number of professional societies including the American College of Physicians, American Federation of Clinical Research, American Heart Association, American College of Cardiology, the Heart Failure Society of America, International Society of Heart Failure, and the American Physiology Society. Dr. Zile has served on the research, educational and program committees of these organizations. He serves on the editorial boards of the Journal of the American College of Cardiology and Circulation and is an editorial consultant to a number of others including Circulation Research, Journal of Clinical Investigation and the American Journal of Physiology. Dr. Zile is a member of the Association of University Cardiologists and a member of the ABIM Subspecialty Board on Cardiovascular Disease. Dr. Zile is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Inappropriate Sinus Tachycardia (IST), Pacemaker Implantation, and Aortic Valve Replacement. Dr. Zile is currently accepting new patients.

Dr. Thomas DiSalvo attended Harvard College and graduated with honors from the University of Cincinnati College of Medicine. Following medical residency and chief residency at Johns Hopkins Hospital in Baltimore and serving on faculty at Johns Hopkins School of Medicine, he completed fellowship training in cardiology at the Massachusetts General Hospital and Harvard Medical School. After ten years of clinical practice as an assistant professor of medicine at Harvard, he was recruited as medical director of the Vanderbilt Heart and Vascular Institute and as associate professor of medicine at Vanderbilt. In 2015, Dr. DiSalvo was recruited as professor of medicine and chief of the division of cardiology at MUSC. Throughout his career, he has been an active and busy clinical cardiologist committed to the highest standards of excellence. As an educator, although he has had the privilege of educating students and physicians in training and lecturing at many national and international cardiology meetings, Dr. DiSalvo enjoys educating patients and their families even more, both in the clinic and at the bedside. Dr. Di Salvo is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Heart Failure, Cardiomyopathy, Pacemaker Implantation, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Di Salvo is currently accepting new patients.

Dr. Scalea is a board-certified surgeon specializing in kidney, pancreas, liver, and islet cell transplantation. Dr. Scalea's patient care philosophy is to treat his patients with a meticulous focus on excellence and compassionate care. His clinical area of expertise is in abdominal organ transplantation, with a special interest in kidney, pancreas, and islet cell transplantation. Dr. Scalea has achieved outstanding results in his simultaneous kidney and pancreas (SPK) transplant recipients. At MUSC Health, he is the Surgical Director of the Kidney Transplant Program and the Director of Hepatology, Nephrology, and Transplant ICCE Quality and Innovation.Dr. Scalea's research interests focus on improving outcomes and access to care for patients needing life-saving transplantation and researching strategies to achieve immune tolerance in allogeneic solid organ transplantation. He received international notoriety in 2019 for pioneering drones for organ transplants. As the inaugural Vice Chair of Surgery for Innovation, Dr. Scalea will expand his experience in clinical medicine, academic leadership, commercialization, and innovation to help translate innovative ideas from the laboratory to industry.Dr. Scalea received his medical degree and surgical training from the University of Maryland and completed his transplant fellowship at the University of Wisconsin and his post-doctoral fellowship at the Harvard Medical School, Transplantation Biology Research Center.When not in the clinic or laboratory, Dr. Scalea enjoys painting and performing music. His artworks are currently on display in Baltimore and Washington, D.C. Dr. Scalea is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Pancreas Transplant, and Kidney Transplant. Dr. Scalea is currently accepting new patients.

Dr. Jan Griffin completed her residency in internal medicine at the University of North Carolina in Chapel Hill and cardiology fellowship at Johns Hopkins Hospital. She then did a fellowship in advanced heart failure and transplant cardiology at Columbia University Irving Medical Center, where she continued as an assistant professor of medicine.Her research focuses on infiltrative cardiomyopathies, particularly cardiac amyloidosis and cardiac sarcoidosis. She is ABIM board certified in internal medicine, cardiology and advanced heart failure and transplant cardiology. Dr. Griffin is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Restrictive Cardiomyopathy (RCM), Arrhythmogenic Right Ventricular Cardiomyopathy, and Heart Transplant. Dr. Griffin is currently accepting new patients.

Dr. Ira Willner is an associate professor of medicine in the Division of Gastroenterology and Hepatology at the Medical University of South Carolina. He is also the director of the fellowship training program for gastroenterology and hepatology. Dr. Willner completed his medical degree (M.D.) at the SUNY Health Science Center in Syracuse, New York in 1990. He then completed a two-year fellowship in gastroenterology at the New York Medical College in Valhalla, New York in 1995, followed by a one-year fellowship in liver disease at the University of Tennessee in 1996. He is board certified in internal medicine and gastroenterology. Dr. Willner is a member of several professional organizations, including the American Association for the Study of Liver Disease, European Association for the Study of the Liver, American College of Physicians, American Medical Association, and the American College of Gastroenterology. Additionally, Dr. Willner was awarded the Department of Internal Medicine attending of the year in 2000. Dr. Willner's clinical interests include liver disease, treatment of portal hypertension, and viral hepatitis. Dr. Willner is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Enlarged Liver, Endoscopy, and Liver Transplant. Dr. Willner is currently accepting new patients.

Dr. Luca Paoletti received his BA in biology from the University of Virginia and his medical degree from St. George's University. He completed internship and residency in internal medicine at the University of Connecticut Medical Center, where he was selected to serve as chief resident. He completed sub-specialty training in pulmonary and critical care medicine at the Medical University of South Carolina, where he is currently an associate professor of medicine and is the Medical Director of the Adult ECMO program and the Medical Director of Pulmonary Rehabilitation. His teaching activities and patient care are focused in the area of pulmonary transplant medicine. Dr. Paoletti is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Bronchiolitis Obliterans, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Bone Marrow Aspiration. Dr. Paoletti is currently accepting new patients.

Amy Osguthorpe Wisse received her BS in biology from Clemson University. She continued her undergraduate education with a Bachelor's in Nursing from the Medical University of South Carolina and then graduated with her Doctor of Nursing Practice degree in 2014. Amy has been with MUSC's lung transplant program since 2015. Mrs. Wisse focuses her clinical and research efforts on chronic lung disease (COPD, ILD, IPF) and post lung transplant patients. Dr. Wisse is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Hypersensitivity Pneumonitis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Lung Transplant. Dr. Wisse is currently accepting new patients.

Dr. Anthony Carnicelli, M.D. is an advanced heart failure and transplant cardiologist and an assistant professor in the Department of Medicine. He specializes in treating patients with all forms of heart failure, including patients with advanced heart failure requiring IV medications, left ventricular assist devices (LVAD), and cardiac transplantation.Dr. Carnicelli earned his medical doctorate degree at the University of Rochester School of Medicine, where he was elected into the Alpha Omega Alpha (AOA) honor medical society. He completed residency training in internal medicine at Harvard Medical School's Brigham and Women's Hospital, where he was awarded the Golden Stethoscope Award for excellence in teaching and clinical acumen. Dr. Carnicelli completed fellowship training in cardiovascular diseases at Duke University as well as advanced training in clinical research at Duke Clinical Research Institute and subspecialty fellowship training in advanced heart failure and transplant cardiology at Duke University.Dr. Carnicelli's clinical interests include cardiovascular critical care, cardiogenic shock, cardiac catheterization, temporary and durable mechanical circulatory support, and cardiac transplantation. He has authored over 30 peer-reviewed original research manuscripts and has been awarded grant funding from the NIH to support his work. Dr. Carnicelli is passionate about teaching and enjoys working with medical students, residents, and fellows. Dr. Carnicelli is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Heart Failure, Heart Attack, Heart Transplant, and Lung Transplant. Dr. Carnicelli is currently accepting new patients.

Alexander Coltoff, M.D. received his medical degree from SUNY Downstate College of Medicine. He then completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, followed by a fellowship in Hematology/Oncology at New York Presbyterian - Columbia, both in New York. His clinical and research focus is on hematologic malignancies, particularly myeloproliferative neoplasms (MPNs), acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS). He has been published as a clinical investigator and received an American Society of Hematology (ASH) award for developing research scientists. Dr. Coltoff is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Coltoff is currently accepting new patients.

Dr. Adrian Van Bakel graduated from the University of Louisville School of Medicine in 1981, completing a Ph.D. in pharmacology from that institution in 1983. He completed internal medicine residency and cardiology fellowship training at the Medical University of South Carolina and has been on the faculty at MUSC since 1991. Dr. Van Bakel served as the Medical Director of the Heart Failure and Cardiac Transplant Program from 1991-2017. He has been an integral part of a multi-disciplinary clinical team that has achieved excellent results in the areas of clinical heart failure management and cardiac transplantation. He is a member of a number of professional societies including: The American College of Physicians; the American Heart Association; the American College of Cardiology; the Heart Failure Society of America; and, the International Society of Heart and Lung Transplantation. He has served as a manuscript reviewer for several journals, such as: The Journal of Cardiac Failure; The Journal of Heart and Lung Transplantation; and, The American Journal of Transplantation. Dr. Van Bakel has been the principal investigator of many multi-center clinical trials in congestive heart failure and cardiac transplantation. His research interests include congestive heart failure management, novel immunosuppression strategies and the pharmacogenomics of drug absorption and metabolism. Dr. Van Bakel is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiomyopathy, Dilated Cardiomyopathy (DCM), Heart Failure with Preserved Ejection Fraction (HFpEF), and Endoscopy. Dr. Van Bakel is currently accepting new patients.

Kathleen Law, FNP, MSN, specializes in Heart Failure & Transplant, and Cardiology. Dr. Law is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), and Arrhythmogenic Right Ventricular Cardiomyopathy. Dr. Law is currently accepting new patients.

Dr. Katherine Antel earned her medical degree from the University of Cape Town, South Africa and where she went on to complete an internal medicine residency and a fellowship in hematology and bone marrow transplant. Dr. Antel went on to pursue 3-year research fellowship in lymphoid genomics at the Dana-Farber Cancer Institute, Boston U.S. Her research area of interest is in lymphoid biology, and lymphoid genomics. Dr. Antel is an associate professor at the Medical University of South Carolina in Charleston. Her clinical and research areas of interest include the biology and genomics of aggressive lymphoma and the development of clinical assays to detect and diagnose lymphoma using cell-free DNA. Dr. Antel is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Lymphofollicular Hyperplasia, Lymphadenitis, Hodgkin Lymphoma, and Burkitt Lymphoma. Dr. Antel is currently accepting new patients.

Dr. Tara Barry is double-board certified in general surgery and surgical critical care; she specializes in liver, kidney, and pancreas transplantation. She is also certified in robotic surgery and performs living donor nephrectomies as well as robotic general surgery procedures. She has dedicated her career to caring for patients with advanced organ disease and is passionate about helping people live longer, healthier lives through transplantation. Dr. Barry trained for more than ten years to provide expert, compassionate care. She earned her medical degree from the University of Maryland and completed her general surgery residency at the University of South Florida, where she also spent two years in clinical research that led to several publications. During residency, she also completed a fellowship in surgical critical care and became certified in robotic surgery. She went on to advanced training in abdominal transplant surgery at Tampa General Hospital, one of the busiest transplant centers in the nation. Her clinical interests include improving outcomes for patients before and after transplant, caring for complex liver patients in the intensive care unit, and developing specialized transplant care programs. She also performs robotic general surgery procedures, including gallbladder removal, hernia repair, and dialysis access surgeries. Dr. Barry believes in caring for the whole patient and their family, not just performing surgery. She works closely with patients to guide them through every step of the transplant process, from evaluation and expectations for surgery to the operation itself and long-term follow-up. She is also active in community outreach and patient education, raising awareness about organ donation and improving access to transplant services. Her goal is to provide excellent care while helping build one of the best transplant programs in the country here at MUSC. Her clinical expertise encompasses Hernia, Polycystic Kidney Disease, and Heart Bypass Surgery. Dr. Barry is currently accepting new patients.

Jessica Atkins, MD, specializes in Heart Failure & Transplant and is located in Charleston, SC. Her clinical expertise encompasses Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant. Dr. Atkins is currently accepting new patients.

Dr. Gregory Jackson is a specialist in advanced heart failure and transplant cardiology. He graduated from the University of Florida with highest honors before receiving his medical degree from the George Washington University School of Medicine and Health Sciences. He completed internal medicine residency training at the Cleveland Clinic, then completed his cardiology fellowship at the Medical University of South Carolina where he served as chief fellow. Dr. Jackson went on to complete the advanced heart failure and transplantation fellowship at the University of North Carolina-Chapel Hill before returning to MUSC as an assistant professor of medicine in the Division of Cardiology.Dr. Jackson is board certified in advanced heart failure and transplant cardiology, cardiovascular disease, echocardiography, and internal medicine. He is a Fellow of the American College of Cardiology (FACC), Fellow of the Heart Failure Society of America (FHFSA), and member of the International Society of Heart and Lung Transplant. He has been an invited speaker, as well as presented his research, at state and national conferences. Dr. Jackson's clinical interests include heart failure, left ventricular assist devices, cardiac transplantation, echocardiography, and cardiac catheterization, and his research interests include the intersection of sleep apnea and cardiovascular disease. His clinical expertise encompasses Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), and Hypertrophic Cardiomyopathy (HCM). Dr. Jackson is currently accepting new patients.

David Koch, MD, MSCR, specializes in Gastroenterology & Hepatology, and Liver Transplant. Dr. Koch is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Liver Failure, Cirrhosis, Hepatitis, Liver Transplant, and Endoscopy. Dr. Koch is currently accepting new patients.

Kara Cole, ANP, specializes in Gastroenterology & Hepatology, and Liver Transplant. Dr. Cole is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Hepatitis C, and Autoimmune Hepatitis. Dr. Cole is currently accepting new patients.

Anthony Dominick, D.O., was born and raised in Kansas City before moving to Chicago, IL, to earn his Bachelor of Science in Biology at Loyola University. He received his medical degree from Lake Erie College of Osteopathic Medicine in Bradenton, FL. He then moved back to his hometown of Kansas City to complete his residency in internal medicine and fellowship in hematology and oncology at The University of Kansas Medical Center. Early on in his training, he was inspired by his mentors and developed a passion for malignant hematology. After completing training, he spent four years in private practice caring for patients with hematologic conditions in eastern North Carolina. He joined MUSC to pursue his interest and passion for caring for patients with multiple myeloma. He also has a secondary clinical interest in lymphoproliferative disorders. Dr. Dominick is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Dominick is currently accepting new patients.

"Dr. Santosh Nagaraju, MD, is a board-certified surgeon specializing in abdominal organ transplant surgeon. Dr. Nagaraju earned his medical degree in India and completed a general surgery residency at Grant Medical College, Mumbai, in India. He pursued organ transplant training as a visiting research scholar at the Thomas E. Starzl Transplantation Institute in Pittsburgh. He then completed a general surgery residency and a multi-organ transplant surgery fellowship at Indiana University.Dr. Nagaraju is certified in kidney, liver, pancreas and intestine transplant by the American Society of Transplant Surgeons. He also performs minimally invasive donor surgery for living donor kidney transplants. Dr. Nagaraju is board certified in general surgery by the American Board of Surgery and performs a spectrum of general surgery procedures including hernia, gall bladder, hepatobiliary and dialysis access procedures. He enjoys working with trainees including medical students, residents and fellows. He is passionate about improving learning experience for trainees.Dr. Nagaraju believes in empowering and educating patients to make the best possible decisions for their healthcare needs. He encourages a team approach that is patient centered and inclusive of providers and patient families to determine care plans that reflect patient autonomy. He believes patients are part of the extended ""transplant family"" and forges long lasting bonds with patients long after their surgery.Outside of work, Dr. Nagaraju enjoys spending time with his daughter, reading and cycling.". Dr. Nagaraju is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, Pancreas Transplant, and Kidney Transplant. Dr. Nagaraju is currently accepting new patients.